| Value | ₹0.10 Cr |
|---|
BSE filing, NSE: CRSTCHM. Summary written from the filing by ALFA Finder's alert engine.
Crestchem Ltd: key numbers
- Share price
- ₹142.75
- Market cap
- ₹42.82 Cr
- Revenue (annual)
- ₹29.61 Cr
- Net profit (annual)
- ₹2.71 Cr
- P/E (TTM)
- 12.8×Sector 34.1×
- Promoter holding
- 29.72%-0.04% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Crestchem Ltd
All →Crestchem Board Meeting Date
Crestchem Limited will hold a board meeting on November 5, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The agenda also allows other items with the Chair's permission.
Crestchem Price Movement Clarification
Crestchem Limited clarified that recent stock price movements are market-driven and not due to any undisclosed material information. The company confirmed compliance with all SEBI disclosure regulations.
Crestchem Other Announcement
Crestchem Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Crestchem Promoter Selling: ₹0.03 Cr
Crestchem Ltd promoters reported market transactions on September 10, 2026. Director Dipak Patel acquired 981 shares while Sonalben Patel sold 1,000 shares.
- Value
- ₹0.03 Cr
Crestchem Promoter Buying
Promoter Dipak Narendraprasad Patel acquired 200 equity shares of Crestchem Ltd via market purchase for ₹0.0026 Crore.
Crestchem Other Announcement
Crestchem Limited issued duplicate share certificates to one shareholder for three lost certificates covering 100 shares. This is a routine administrative filing with no financial impact.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.